|
1
|
Hallahan AR, Shaw PJ, Rowell G, O’Connell
A, Schell D and Gillis J: Improved outcomes of children with
malignancy admitted to a pediatric intensive care unit. Crit Care
Med. 28:3718–3721. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Booy R, Habibi P, Nadel S, et al:
Reduction in case fatality rate from meningococcal disease
associated with improved healthcare delivery. Arch Dis Child.
85:386–390. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tenner PA, Dibrell H and Taylor RP:
Improved survival with hospitalists in a pediatric intensive care
unit. Crit Care Med. 31:847–852. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Yan-jun WF: Study on pathogens
causing lower respiratory tract infections and their drug
resistance. Zhong Guo Bing Yuan Sheng Wu Xue Za Zhi. 8:561–563.
2013.(In Chinese).
|
|
5
|
Adair CG, Gorman SP, Feron BM, et al:
Implications of endotracheal tube biofilm for ventilator-associated
pneumonia. Intensive Care Med. 25:1072–1076. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Crump JA and Collignon PJ: Intravascular
catheter-associated infections. Eur J Clin Microbiol Infect Dis.
19:1–8. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maki DG and Tambyah PA: Engineering out
the risk for infection with urinary catheters. Emerg Infect Dis.
7:342–347. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Douglas LJ: Candida biofilms and
their role in infection. Trends Microbiol. 11:30–36. 2003.
View Article : Google Scholar
|
|
9
|
Blankenship JR and Mitchell AP: How to
build a biofilm: a fungal perspective. Curr Opin Microbiol.
9:588–594. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chandra J, Mukherjee PK and Ghannoum MA:
In vitro growth and analysis of Candida biofilms. Nat
Protoc. 3:1909–1924. 2008. View Article : Google Scholar
|
|
11
|
Carlson RP, Taffs R, Davison WM and
Stewart PS: Anti-biofilm properties of chitosan-coated surfaces. J
Biomater Sci Polym Ed. 19:1035–1046. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alonso MJ and Sánchez A: The potential of
chitosan in ocular drug delivery. J Pharm Pharmacol. 55:1451–1463.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kulikov SN, Tiurin IuA, Fassakhov RS and
Varlamov VP: Antibacterial and antimycotic activity of chitosan:
mechanisms of action and role of the structure. Zh Mikrobiol
Epidemiol Immunobiol. 5:91–97. 2009.(In Russian).
|
|
14
|
Pasquantonio G, Greco C, Prenna M, et al:
Antibacterial activity and anti-biofilm effect of chitosan against
strains of Streptococcus mutans isolated in dental plaque.
Int J Immunopathol Pharmacol. 21:993–997. 2008.PubMed/NCBI
|
|
15
|
Meshulam T, Levitz SM, Christin L and
Diamond RD: A simplified new assay for assessment of fungal cell
damage with the tetrazolium dye,
(2,3)-bis-(2-methoxy-4-nitro-5-sul-
phenyl)-(2H)-tetrazolium-5-carboxanilide (XTT). J Infect Dis.
172:1153–1156. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsang PW, Bandara HM and Fong WP: Purpurin
suppresses Candida albicans biofilm formation and hyphal
development. PLoS One. 7:e508662012.PubMed/NCBI
|
|
17
|
Albani JR and Plancke YD: Interaction
between calcofluor white and carbohydrates of alpha 1-acid
glycoprotein. Carbohydr Res. 314:169–175. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wisplinghoff H, Ebbers J, Geurtz L,
Stefanik D, Major Y, Edmond MB, Wenzel RP and Seifert H: Nosocomial
bloodstream infections due to Candida spp. in the USA:
species distribution, clinical features and antifungal
susceptibilities. Int J Antimicrob Agents. 43:78–81. 2014.
|
|
19
|
Georgopapadakou NH and Walsh TJ: Human
mycoses: drugs and targets for emerging pathogens. Science.
264:371–373. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ramage G, VandeWalle K, Bachmann SP,
Wickes BL and López-Ribot JL: In vitro pharmacodynamic properties
of three antifungal agents against preformed Candida
albicans biofilms determined by time-kill studies. Antimicrob
Agents Chemother. 46:3634–3636. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martinez LR, Mihu MR, Tar M, et al:
Demonstration of antibiofilm and antifungal efficacy of chitosan
against candidal biofilms, using an in vivo central venous catheter
model. J Infect Dis. 201:1436–1440. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hawser SP and Douglas LJ: Resistance of
Candida albicans biofilms to antifungal agents in vitro.
Antimicrob Agents Chemother. 39:2128–2131. 1995.
|
|
23
|
Mukherjee PK, Chandra J, Kuhn DM and
Ghannoum MA: Mechanism of fluconazole resistance in Candida
albicans biofilms: phase-specific role of efflux pumps and
membrane sterols. Infect Immun. 71:4333–4340. 2003.PubMed/NCBI
|
|
24
|
Rabea EI, Badawy ME, Stevens CV, Smagghe G
and Steurbaut W: Chitosan as antimicrobial agent: applications and
mode of action. Biomacromolecules. 4:1457–1465. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sudarshan NR, Hoover DG and Knorr D:
Antibacterial action of chitosan. Food Biotechnol. 6:257–272. 1992.
View Article : Google Scholar
|
